Physician profile
Michael C Bard
NPI 1255336616
$1,936.86
in general payments reported to CMS, 2019-2025
19 companies · $644 in 2025
The $644 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.83 · 2021: $88.31 · 2022: $580 · 2023: $301 · 2024: $279 · 2025: $644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,224.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $556.38 | 2022-2025 | Inspire |
| Glaxosmithkline, LLC. | $385.21 | 2022-2025 | Nucala |
| Checkpoint Surgical, INC | $158.72 | 2021-2022 | |
| Endo USA, INC. | $155.52 | 2024-2025 | Xiaflex |
| Regeneron Healthcare Solutions, INC. | $128.25 | 2021-2025 | Dupixent, Libtayo |
| Stryker Corporation | $79.35 | 2019-2023 | Xpress Ent Dilation System |
| Smith+Nephew, INC. | $78.15 | 2023-2025 | Tula, Stravix |
| Optinose US, INC. | $71.40 | 2025 | |
| Incyte Corporation | $53.11 | 2025 | Opzelura |
| Abbvie INC. | $50.57 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Amgen INC. | $42.31 | 2025 | Tezspire, Tavneos |
| Hikma Pharmaceuticals USA | $29.00 | 2022-2023 | Ryaltris |
| Musculoskeletal Transplant Foundation INC. | $26.00 | 2023 | |
| Medtronic, INC. | $25.35 | 2025 | Pteye Parathyroid Detection System |
| Merck Sharp & Dohme LLC | $23.73 | 2025 | Keytruda |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $19.64 | 2025 | Voquezna |
| Genzyme Corporation | $19.30 | 2019 | |
| Solventum Corporation | $18.16 | 2024 | Activ.A.C., Promogran Prisma |
| Integra Lifesciences Corporation | $16.71 | 2025 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.